JPH01125328A - 髄膜炎菌ワクチン - Google Patents
髄膜炎菌ワクチンInfo
- Publication number
- JPH01125328A JPH01125328A JP63190500A JP19050088A JPH01125328A JP H01125328 A JPH01125328 A JP H01125328A JP 63190500 A JP63190500 A JP 63190500A JP 19050088 A JP19050088 A JP 19050088A JP H01125328 A JPH01125328 A JP H01125328A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- treatment
- chromatography
- meningococcus
- molecular weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- 150000004676 glycans Chemical class 0.000 claims abstract description 7
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 7
- 239000005017 polysaccharide Substances 0.000 claims abstract description 7
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 6
- 239000002671 adjuvant Substances 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims abstract description 4
- 239000004094 surface-active agent Substances 0.000 claims abstract description 4
- 102000004190 Enzymes Human genes 0.000 claims abstract description 3
- 108090000790 Enzymes Proteins 0.000 claims abstract description 3
- 238000001042 affinity chromatography Methods 0.000 claims abstract description 3
- 238000010494 dissociation reaction Methods 0.000 claims abstract description 3
- 230000005593 dissociations Effects 0.000 claims abstract description 3
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 3
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 3
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 3
- 102000036639 antigens Human genes 0.000 claims abstract 5
- 108091007433 antigens Proteins 0.000 claims abstract 5
- 239000000427 antigen Substances 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract 2
- 238000000746 purification Methods 0.000 claims abstract 2
- 230000001717 pathogenic effect Effects 0.000 claims description 12
- 230000000890 antigenic effect Effects 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241000588650 Neisseria meningitidis Species 0.000 claims description 3
- 230000004044 response Effects 0.000 claims description 3
- 230000001948 anti-meningococcal effect Effects 0.000 claims description 2
- 230000007969 cellular immunity Effects 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 239000002158 endotoxin Substances 0.000 claims description 2
- 108010074605 gamma-Globulins Proteins 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- 230000000521 hyperimmunizing effect Effects 0.000 claims description 2
- 230000005847 immunogenicity Effects 0.000 claims description 2
- 230000002779 inactivation Effects 0.000 claims description 2
- 238000004255 ion exchange chromatography Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 230000003472 neutralizing effect Effects 0.000 claims description 2
- 238000000527 sonication Methods 0.000 claims description 2
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 1
- 230000005875 antibody response Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 238000009210 therapy by ultrasound Methods 0.000 abstract 2
- 230000009849 deactivation Effects 0.000 abstract 1
- 230000007123 defense Effects 0.000 abstract 1
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
- 206010058858 Meningococcal bacteraemia Diseases 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 208000022089 meningococcemia Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU125/87 | 1987-07-30 | ||
| CU1987125 | 1987-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH01125328A true JPH01125328A (ja) | 1989-05-17 |
Family
ID=5459411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63190500A Pending JPH01125328A (ja) | 1987-07-30 | 1988-07-29 | 髄膜炎菌ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5597572A (cg-RX-API-DMAC10.html) |
| EP (1) | EP0301992B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JPH01125328A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE122893T1 (cg-RX-API-DMAC10.html) |
| AU (3) | AU615461B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA1341199C (cg-RX-API-DMAC10.html) |
| DE (1) | DE3853854T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2074445T3 (cg-RX-API-DMAC10.html) |
| GR (1) | GR3017218T3 (cg-RX-API-DMAC10.html) |
| IN (1) | IN167607B (cg-RX-API-DMAC10.html) |
| RU (1) | RU2023448C1 (cg-RX-API-DMAC10.html) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2070312T5 (es) * | 1988-12-19 | 2003-05-16 | American Cyanamid Co | Vacuna de proteina de membrana exterior meningococica de clase 1. |
| US7118757B1 (en) | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
| CU22302A1 (es) * | 1990-09-07 | 1995-01-31 | Cigb | Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales |
| ATE190502T1 (de) | 1993-05-13 | 2000-04-15 | American Cyanamid Co | Herstellung und verwendungen von los-verminderten aussenmembran-proteinen von gram-negativen kokken |
| US6287574B1 (en) | 1995-03-17 | 2001-09-11 | Biochem Pharma Inc. | Proteinase K resistant surface protein of neisseria meningitidis |
| PT854729E (pt) * | 1995-09-18 | 2004-08-31 | Us Army Med Res Mat Com Usamrm | Metodos melhorados para a producao de vacinas de subunidade multivalentes de proteossomas complexados nao covalentemente |
| FR2751000B1 (fr) * | 1996-07-12 | 1998-10-30 | Inst Nat Sante Rech Med | Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques |
| US6558677B2 (en) * | 1996-10-15 | 2003-05-06 | Wendell D. Zollinger | Vaccine against gram negative bacteria |
| RU2347813C2 (ru) * | 1997-11-06 | 2009-02-27 | Чирон С.П.А. | Антигены нейссерий |
| GB9726398D0 (en) | 1997-12-12 | 1998-02-11 | Isis Innovation | Polypeptide and coding sequences |
| GB9808734D0 (en) * | 1998-04-23 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| GB9808866D0 (en) | 1998-04-24 | 1998-06-24 | Smithkline Beecham Biolog | Novel compounds |
| GB9810276D0 (en) | 1998-05-13 | 1998-07-15 | Smithkline Beecham Biolog | Novel compounds |
| GB9811260D0 (en) * | 1998-05-26 | 1998-07-22 | Smithkline Beecham Biolog | Novel compounds |
| GB9823978D0 (en) | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
| US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
| HK1042515A1 (zh) * | 1999-01-22 | 2002-08-16 | Smithkline Beecham Biologicals S.A. | 來自腦膜炎球菌的basb055多核苷酸和多肽，其使用法 |
| NZ545647A (en) | 1999-05-19 | 2008-02-29 | Chiron Srl | Combination neisserial compositions |
| GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| GB9929923D0 (en) * | 1999-12-17 | 2000-02-09 | Baldwin Thomas J | Antigen preparations |
| AU2001280883A1 (en) | 2000-07-27 | 2002-02-13 | The Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| GB0103170D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| GB0103171D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| RU2355704C2 (ru) * | 2001-04-17 | 2009-05-20 | Новартис Вэксинс Энд Диагностикс, Инк | Моноклональное антитело, направленное против gna33 пептида, и его применение |
| CN1306956C (zh) * | 2001-04-17 | 2007-03-28 | 希龙公司 | 诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物 |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| IL145926A0 (en) * | 2001-10-15 | 2002-07-25 | Mor Research Applic Ltd | Peptide epitopes of mimotopes useful in immunomodulation |
| CU22983A1 (es) * | 2002-05-08 | 2004-09-09 | Inst Finlay | Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas |
| US20040096461A1 (en) * | 2002-07-30 | 2004-05-20 | Baxter Healthcare Corporation | Chimeric multivalent polysaccharide conjugate vaccines |
| JP4740738B2 (ja) | 2002-08-02 | 2011-08-03 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| EP2279746B1 (en) | 2002-11-15 | 2013-10-02 | Novartis Vaccines and Diagnostics S.r.l. | Surface proteins in neisseria meningitidis |
| GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| CU23313A1 (es) | 2002-11-27 | 2008-09-25 | Inst Finlay Ct De Investigacia | Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios |
| EP2191844B1 (en) | 2003-01-30 | 2014-03-05 | Novartis AG | Injectable vaccines against multiple meningococcal serogroups |
| US20040241190A1 (en) * | 2003-04-07 | 2004-12-02 | Xenova Research Limited | Vaccine preparations |
| RU2250113C2 (ru) * | 2003-06-04 | 2005-04-20 | Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук | Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции |
| GB0316560D0 (en) * | 2003-07-15 | 2003-08-20 | Chiron Srl | Vesicle filtration |
| GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
| CU23420A1 (es) * | 2003-12-30 | 2009-09-08 | Univ De Cambridge | Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes |
| GB0406013D0 (en) | 2004-03-17 | 2004-04-21 | Chiron Srl | Analysis of saccharide vaccines without interference |
| GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| GB0411387D0 (en) | 2004-05-21 | 2004-06-23 | Chiron Srl | Analysis of saccharide length |
| GB0413868D0 (en) | 2004-06-21 | 2004-07-21 | Chiron Srl | Dimensional anlaysis of saccharide conjugates |
| GB0416120D0 (en) | 2004-07-19 | 2004-08-18 | Health Prot Agency | Stable compositions containing OMV's |
| GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| EP2682126B1 (en) | 2005-01-27 | 2016-11-23 | Children's Hospital & Research Center at Oakland | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
| KR101408113B1 (ko) | 2005-06-27 | 2014-06-16 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 제조 방법 |
| GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
| GB0605757D0 (en) | 2006-03-22 | 2006-05-03 | Chiron Srl | Separation of conjugated and unconjugated components |
| US7943352B2 (en) | 2006-03-29 | 2011-05-17 | Bacoustics, Llc | Apparatus and methods for vaccine development using ultrasound technology |
| US8414899B2 (en) | 2006-04-11 | 2013-04-09 | Yeda Research And Development Co. Ltd. | Vaccines comprising multimeric HSP60 peptide carriers |
| EA200970731A1 (ru) * | 2007-02-07 | 2010-02-26 | Сигма-Тау Индустрие Фармасьютике Риуните С.П.А. | Рекомбинантные антигены цитомегаловируса человека (hcmv) |
| BRPI0907843A2 (pt) | 2008-02-21 | 2015-08-04 | Novartis Ag | Polipeptídeos de fhbp menigocócicos |
| CU20080215A7 (es) | 2008-11-19 | 2012-06-21 | Inst Finlay | Vacunas unitemporales |
| CN102596240B (zh) | 2009-08-27 | 2015-02-04 | 诺华股份有限公司 | 包括脑膜炎球菌fHBP序列的杂交多肽 |
| BR112012010531A2 (pt) | 2009-10-27 | 2019-09-24 | Novartis Ag | "polipeptídeos de modificação meningocócica fhbp" |
| CN102869377A (zh) | 2010-03-10 | 2013-01-09 | 葛兰素史密丝克莱恩生物有限公司 | 免疫原性组合物 |
| CU20100083A7 (es) | 2010-05-05 | 2012-06-21 | Inst Finlay | Tolerogenos adyuvados como vacuna de malaria |
| PT2608805T (pt) | 2010-08-23 | 2017-09-11 | Wyeth Llc | Formulações estáveis de antigénios de rlp2086 de neisseria meningitidis |
| GB201015132D0 (en) | 2010-09-10 | 2010-10-27 | Univ Bristol | Vaccine composition |
| CN103096920B (zh) | 2010-09-10 | 2016-03-23 | 惠氏有限责任公司 | 脑膜炎奈瑟球菌orf2086抗原的非脂质化变体 |
| CU20110202A7 (es) * | 2011-11-02 | 2013-12-27 | Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas | Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes |
| JP5925342B2 (ja) | 2012-03-09 | 2016-05-25 | ファイザー・インク | 髄膜炎菌（Ｎｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ）組成物およびその方法 |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| EP2689775A1 (en) | 2012-07-25 | 2014-01-29 | Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros | Cochleate with only one mamp |
| ES2685894T3 (es) | 2013-03-08 | 2018-10-15 | Pfizer Inc. | Polipéptidos de fusión inmunogénicos |
| CA2923129C (en) | 2013-09-08 | 2020-06-09 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| EP3110442B1 (en) | 2014-02-28 | 2020-10-14 | GlaxoSmithKline Biologicals SA | Modified meningococcal fhbp polypeptides |
| KR20170103009A (ko) | 2015-02-19 | 2017-09-12 | 화이자 인코포레이티드 | 나이세리아 메닌지티디스 조성물 및 그의 방법 |
| IL303108B2 (en) | 2017-01-31 | 2024-07-01 | Pfizer | NEISSERIA MENINGITIDIS preparations and methods therefor |
| RU2659948C1 (ru) * | 2017-03-14 | 2018-07-04 | Федеральное государственное бюджетное научноеучреждение "Омский аграрный научный центр" (ФГБНУ "Омский АНЦ") | Способ получения R-бруцеллёзной сыворотки на кроликах |
| CN110157767A (zh) * | 2019-04-18 | 2019-08-23 | 金花企业(集团)股份有限公司 | 一种转移因子口服溶液生物活性测定方法 |
| EP4034157A1 (en) | 2019-09-27 | 2022-08-03 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271147A (en) * | 1980-01-10 | 1981-06-02 | Behringwerke Aktiengesellschaft | Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same |
| US4386066A (en) * | 1981-08-20 | 1983-05-31 | Merck & Co., Inc. | Immunogenic complex from N. gonorrhoeae |
| US4451446A (en) * | 1982-03-04 | 1984-05-29 | Smithkline-Rit | Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them |
| US4885005A (en) * | 1982-11-12 | 1989-12-05 | Baxter International Inc. | Surfactant treatment of implantable biological tissue to inhibit calcification |
| EP0109688A3 (en) * | 1982-11-23 | 1986-12-03 | The Wellcome Foundation Limited | Improved complexes, processes for obtaining them and formulations containing such complexes |
| US4505853A (en) * | 1983-11-18 | 1985-03-19 | Ortho Pharmaceutical Corporation | Enzyme-resistant immunomodulatory peptides |
| US4547489A (en) * | 1984-06-11 | 1985-10-15 | Ortho Pharmaceutical Corporation | Conformationally restricted thymopentin-like compounds |
| US4629723A (en) * | 1984-06-27 | 1986-12-16 | Ortho Pharmaceutical Corporation | Potent thymopentin analogs |
| US4601903A (en) * | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
| US4838888A (en) * | 1987-04-17 | 1989-06-13 | Baxter Travenol Laboratories, Inc. | Calcification mitigation of implantable bioprostheses |
-
1988
- 1988-07-29 RU SU884356456A patent/RU2023448C1/ru not_active IP Right Cessation
- 1988-07-29 JP JP63190500A patent/JPH01125328A/ja active Pending
- 1988-07-30 EP EP88500077A patent/EP0301992B1/en not_active Expired - Lifetime
- 1988-07-30 AT AT88500077T patent/ATE122893T1/de not_active IP Right Cessation
- 1988-07-30 DE DE3853854T patent/DE3853854T2/de not_active Expired - Lifetime
- 1988-07-30 ES ES88500077T patent/ES2074445T3/es not_active Expired - Lifetime
- 1988-08-01 AU AU20312/88A patent/AU615461B2/en not_active Ceased
- 1988-08-01 CA CA000573538A patent/CA1341199C/en not_active Expired - Fee Related
- 1988-09-06 IN IN626/MAS/88A patent/IN167607B/en unknown
-
1991
- 1991-07-25 AU AU81349/91A patent/AU8134991A/en not_active Abandoned
-
1993
- 1993-11-12 US US08/152,938 patent/US5597572A/en not_active Expired - Lifetime
-
1994
- 1994-01-14 AU AU53197/94A patent/AU5319794A/en not_active Abandoned
-
1995
- 1995-08-24 GR GR950402324T patent/GR3017218T3/el unknown
-
1996
- 1996-08-02 US US08/692,055 patent/US5747653A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5597572A (en) | 1997-01-28 |
| DE3853854T2 (de) | 1996-02-08 |
| RU2023448C1 (ru) | 1994-11-30 |
| AU5319794A (en) | 1994-03-24 |
| EP0301992A3 (en) | 1990-02-14 |
| IN167607B (cg-RX-API-DMAC10.html) | 1990-11-24 |
| ES2074445T3 (es) | 1995-09-16 |
| CA1341199C (en) | 2001-03-06 |
| US5747653A (en) | 1998-05-05 |
| EP0301992A2 (en) | 1989-02-01 |
| AU615461B2 (en) | 1991-10-03 |
| ATE122893T1 (de) | 1995-06-15 |
| EP0301992B1 (en) | 1995-05-24 |
| AU2031288A (en) | 1989-05-25 |
| AU8134991A (en) | 1991-10-31 |
| GR3017218T3 (en) | 1995-11-30 |
| DE3853854D1 (de) | 1995-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH01125328A (ja) | 髄膜炎菌ワクチン | |
| Andrews et al. | Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge | |
| Verstreate et al. | Outer membrane proteins of Brucella abortus: isolation and characterization | |
| RU2194531C2 (ru) | Поливалентные ассоциированные коклюшно-дифтерийно-столбнячно (акдс)-полиомиелитные вакцины | |
| ES2198405T3 (es) | Antigenos de superficie de tipo i asociados a staphylococcus epidermis. | |
| JP2841094B2 (ja) | 在郷軍人病ワクチン及びその製造方法 | |
| DE69622555T2 (de) | Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung | |
| Potter et al. | Protective capacity of the Pasteurella haemolytica transferrin-binding proteins TbpA and TbpB in cattle | |
| Cryz Jr et al. | Safety and immunogenicity of a polyvalentKlebsiella capsular polysaccharide vaccine in humans | |
| JPS58162531A (ja) | 細菌莢膜由来の多糖類−蛋白質複合体の製法、その生成物およびそれを含有する免疫原組成物 | |
| AU635062B2 (en) | Escherichia coli vaccine | |
| JPH11507805A (ja) | 非細胞性百日咳ワクチンおよびその製造方法 | |
| NO175735B (no) | Fremgangsmåte ved fremstilling av Pasteurella-vaksine | |
| PT90310B (pt) | Processo para a obtencao de preparacoes de adenilato-ciclase | |
| PT680765E (pt) | Vacina para estirpe não tipável de haemophilus influenzae. | |
| Nejati et al. | Biological and immunological evaluation of Neisseria meningitidis serogroup A outer Membrane vesicle as vaccine candidates | |
| JP4530317B2 (ja) | 減毒化トキシンを含むワクチン製剤 | |
| Petersen et al. | The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans | |
| IL30168A (en) | Antigen-free vaccine and process for preparing it | |
| Cross | Development of an anti-endotoxin vaccine for sepsis | |
| Munoz | I. IMMUNOLOGICAL AND OTHER BIOLOGICAL ACTIVITIES OF BORDETELLA PERTUSSIS ANTIGENS | |
| Gilsdorf et al. | Reactivity of Haemophilus influenzae type b anti-pili antibodies | |
| Han et al. | Comparative biological activity of endotoxin and synthetic polyribonucleotides | |
| Arko et al. | Complement-enhanced immunity to infection with Neisseria gonorrhoeae in mice | |
| AU706213B2 (en) | Method for obtaining a vaccine with wide protective range against group B Neisseria Meningitidis, the resulting vaccine, gammaglobulin and transfer factor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Effective date: 20050728 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Effective date: 20050927 Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20051025 |
|
| R150 | Certificate of patent (=grant) or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081111 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 4 Free format text: PAYMENT UNTIL: 20091111 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 5 Free format text: PAYMENT UNTIL: 20101111 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101111 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 6 Free format text: PAYMENT UNTIL: 20111111 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 7 Free format text: PAYMENT UNTIL: 20121111 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 8 Free format text: PAYMENT UNTIL: 20131111 |